BTV-vector-host interaction: the epidemiological triangle in disease transmission

• Autorzy: Niedbalski W.
• Języki publikacji: EN

Abstrakty

EN

Understanding the interaction between the bluetongue virus (BTV), the Culicoides vector and the ruminant host is essential to control bluetongue (BT). This triangle of interaction can be understood individually at the level of the virus, the level of vector and the host level. BTV-vector-host interactions involve physiological and ecological mechanisms, and they have evolved under a specific set of environmental conditions. Recent advances in understanding this interaction include increased knowledge of the virus replication cycle, BTV immunology and pathogenesis in the vertebrate host, as well as the virulence and pathogenicity features of newly discovered BTV serotypes. To understand the virus-host-vector interaction, new molecular biology techniques and experimental infection biology methods have been widely used. The next-generation sequencing, the establishment of a reverse genetics system for the virus, and development of novel infection models and refinement of the existing BTV experimental infection methodologies have proven very helpful. This progress in biotechnology has also made it possible to develop new-generation BTV vaccines, such as disabled infectious single cycle (DISC) vaccines and disabled infectious single animal (DISA) vaccines. However, several questions still need to be answered, such as those concerning cellular pathways involved in the induction of innate immunity and the function of NS4 in the BTV replication cycle. In addition, the identities of specific molecular determinants and the role of quasi-species diversity in determining BTV phenotype are still unclear and should be better explained.

Słowa kluczowe

EN

bluetongue virus; bluetongue disease; Reoviridae; Orbivirus; hemorrhagic disease; Culicoides vector; host; mammal host; ruminant; interaction; epidemiology; disease transmission; virulence; pathogenicity

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2018
• Tom: 74
• Numer: 11
• Opis fizyczny: p.697-701,fig.,ref.

Twórcy

autor

Niedbalski W.

• Department of Foot and Mouth Disease, National Veterinary Research Institute, Wodna 7, 98-220 Zdunska Wola, Poland

Bibliografia

• Backx A., Heutink R., Van-Rooij E., Van-Rijn P.: Transplacental and oral transmission of wild-type bluetongue virus serotype 8 in cattle after experimental infection. Vet. Microbiol. 2009, 138, 235-243.
• Barros S. C., Ramos F., Luis T. M., Vaz A., Duarte M., Henriques M., Cruz B., Fevereiro M.: Molecular epidemiology of bluetongue virus in Portugal during 2004-2006 outbreak. Vet. Microbiol. 2007, 124, 25-34.
• Batten C. A., Henstock M. R., Steedman H. M., Waddington S., Edwards L., Oura C. A.: Bluetongue virus serotype 26: infection kinetics, pathogenesis and possible contact transmission in goats. Vet. Microbiol. 2013, 162, 62-67.
• Batten C. A., Maan S., Shaw A. E., Maan N. S., Mertens P. P.: A European field strains of bluetongue virus derived from two parental vaccine strains by genome segment reassortment. Virus Res. 2008, 137, 56-63.
• Calvo-Pinilla E., Rodriguez-Calvo T., Anguita J., Sevilla N., Ortego J.: Establishment of a bluetongue virus infection model in mice that are deficient in the alpha/beta interferon receptor. PLoS One 2009, 4. doi: 10.1371/journal.pone.0005171.
• Caporale M., Di Gialleonardo L., Janowicz A., Wilkie G., Shaw A., Savini G., van Rijn P. A., Mertens P., Di Ventura M., Palmarini M.: Virus and host factors affecting the clinical overcome of bluetongue virus infection. J. Virol. 2014, 88, 10399-10411.
• Chaignat V., Worwa G., Scherrer N., Hilbe M., Ehrensperger F., Batten C., Cortyen M., Hofmann M., Thuer B.: Toggenburg Orbivirus, a new bluetongue virus: initial detection, first observation in field and experimental infection of goats and sheep. Vet. Microbiol. 2009, 138, 11-19.
• Chauveau E., Doceul V., Lara E., Adam M., Breard E., Sailleau C., Viarouge C., Desprat A., Meyer G., Schwartz-Cornil I., Ruscanu S., Charley B., Zientara S., Vitour D.: Sensing and control of bluetongue virus infection in epithelial cells via RIG-I and MDA5 helicases. J. Virol. 2012, 86, 11789-11799.
• Clausen P. H., Stephan A., Bartsch S., Jandowsky A., Hoffmann-Kohler P., Schein E., Mehlitz D., Bauer B.: Seasonal dynamics of bitting midges (Diptera: Ceratopogonidae, Culicoides spp.) on dairy farms of Central Germany during the 2007/2008 epidemic of bluetongue. Parasitol. Res. 2009, 105, 381-386.
• Coetzee P., van Vuuren M., Venter E. H., Stokstad M.: A review of experimental infection with bluetongue virus in the mammalian host. Virus Res. 2014, 182, 21-34.
• Darpel K. E., Langner K. F., Nimtz M., Anthony S. J., Brownlie J., Takamatsu H. H., Mellor P. S., Mertens P. P.: Saliva proteins of vector Culicoides modify structure and infectivity of bluetongue virus particles. PLoS One, 2011, 6. doi: 10.1371/journal.pone.0017545.
• Darpel K. E., Monaghan P., Simpson J., Anthony S. J., Veronesi E., Brooks H. W., Elliott H., Brownlie J., Takamatsu H. H., Mellor P. S., Mertens P. P.: Involvement of the skin during bluetongue virus infection and replication in the ruminant host. Vet. Res. 2012, 43, 40. doi: 10.1186/1297-9716-43-40.
• Drew C. P., Gardner I. A., Mayo C. E., Matsuo E., Roy P., MacLachlan N. J.: Bluetongue virus infection alters the impedance of monolayers of bovine endothelial cells as a result of cell death. Vet. Immunol. Immunopathol. 2010, 136, 108-115.
• Feenstra F., van Gennip R. G., Maris-Veldhuis M., Verheij E., van Rijn P. A.: Bluetongue virus without NS3/NS3a expression is not virulent and protects against virulent BTV challenge. J. Gen. Virol. 2014, 95, 2019-2029.
• Gallana M., Ryser-Degiorgis M.-P., Wahli T., Segner H.: Climate change and infectious disease of wildlife: Altered interactions between pathogens, vectors and hosts. Curr. Zool. 2013, 59, 427-437.
• Gold S., Monaghan P., Mertens P., Jackson T.: A clathrin independent micropinocytosis-like entry mechanism used by bluetongue virus-1 during infection of BHK cells. PLoS One 2010. doi: 10.1371/journal.pone.0011360.
• Hemati B., Contreras V., Urien C., Bonneau M., Takamatsu H. H., Mertens P. P., Breard E., Sailleau C., Zientara S., Schwartz-Cornil I.: Bluetongue virus targets conventional dendritic cells in skin lymph. J. Virol. 2009, 83, 8789-8799.
• Huismans H., van Staden V., Fick W. C., van Niekerk M., Meiring T. L.: A comparison of different orbivirus proteins that could affect virulence and pathogenesis. Vet. Ital. 2004, 40, 417-425.
• Kirkland P., Hawkes R. A.: A comparison of laboratory and “wild“ strains of bluetongue virus – is there any difference and does it matter? Vet. Ital. 2004, 40, 448-455.
• Leemans J., Raes M., Vanbist T., De Clerck K., Saegerman C., Kirschvink N.: Viral RNA load in semen from bluetongue serotype 8-infected rams: relationship with sperm quality. Vet. J. 2012, 192, 304-310.
• Maclachlan N. J.: Bluetongue: history, global epidemiology, and pathogenesis. Prev. Vet. Med. 2011, 102, 107-111.
• Matsuo E., Celma C. C., Boyce M., Viarouge C., Sailleau C., Dubois E., Breard E., Thiery R., Zientara S., Roy P.: Generation of replication-defective virus-based vaccines that confer full protection in sheep against virulent bluetongue virus challenge. J. Virol. 2011, 85, 10213-10221.
• Matuschka F. R., Fischer P., Heiler M., Richter D., Spielman A.: Capacity of European animals as reservoir host for the Lyme disease spirochete. J. Infect. Dis. 1992, 165, 479-483.
• Meiswinkel R., van Rijn P., Leijs P., Goffredo M.: Potential new Culicoides vector of bluetongue virus in Northern Europe. Vet. Rec. 2007, 161, 564-565.
• Mellor P. S., Boorman J., Baylis M.: Culicoides biting midges: their role as arbovirus vectors. Annu. Rev. Entomol. 2000, 45, 307-340.
• Menzies F. D., McCullough S. J., McKeown I. M., Forster J. L., Jess S., Batten C., Murchie A. K., Gloster J., Fallows J. G., Pelgrim W., Mellor P. S., Oura C. A.: Evidence for transplacental and contact transmission of bluetongue virus in cattle. Vet. Rec. 2008, 163, 203-209.
• Mertens P. P., Burroughs J. N., Walton A., Wellby M. P., Fu H., O’Hara R. S., Brookes S. M., Mellor P. S.: Enhanced infectivity of modified bluetongue virus particles for two insect cells lines and for two Culicoides vector species. Virology 1996, 217, 582-593.
• Mertens P. P., Diprose J.: The bluetongue virus core: a nano-scale transcription machine. Virus Res. 2004, 101, 29-43.
• Mohl B. P., Roy P.: Bluetongue virus capsid assembly and maturation. Viruses 2014, 6, 3250-3270.
• Noad R., Roy P.: Bluetongue vaccines. Vaccine 2009, Suppl. 4, D86-89. doi: 101016/j.vaccine.2009.08.037.
• Roy P.: Bluetongue virus proteins and particles and their role in virus entry, assembly, and release. Adv. Virus Res. 2005, 64, 69-123.
• Ruscanu S., Pascale F., Bourge M., Hemati B., Elhmouzi-Younes J., Urien C., Bonneau M., Takamatsu H., Hope J., Mertens P., Meyer G., Stewart M., Roy P., Meurs E. F., Dabo S., Zientara S., Breard E., Sailleau C., Chauveau E., Vitour D., Charley B., Schwartz-Cornil I.: The double-stranded RNA bluetongue virus induces type 1 interferon in plasmacytoid dendritic cells via a MYD88-dependent TLR7/8-independent signaling pathway. J. Virol. 2012, 86, 5817-5828.
• Sanchez-Cordon P. J., Pedrera M., Risalde M. A., Molina V., Rodriguez-Sanchez B., Nunez A., Sanchez-Vizcaino J., Gomez-Villamandos J. C.: Potential role of proinflammatory cytokines in the pathogenic mechanisms of vascular lesions in goats naturally infected with bluetongue virus serotype 1. Transbound. Emerg. Dis. 2012, 60, 252-262.
• Veronesi E., Darpel K. E., Hamblin C., Carpenter S., Takamatsu H. H., Anthony S. J., Elliott H., Mertens P. P., Mellor P. S.: Viraemia and clinical disease in Dorset Poll sheep following vaccination with live attenuated bluetongue virus vaccines serotypes 16 and 4. Vaccine 2010, 28, 1397-1403.
• Verwoerd D. W.: History of orbivirus research in South Africa. J. S. Afr. Vet. Assoc. 2012, 83:532. doi: 10.4102/jsava.v83i1.532
• Walton T. E.: The history of bluetongue and a current global overview. Vet. Ital. 2004, 40, 31-38.
• Wikel S. K.: Tick modulation of host immunity, an important factor in pathogen transmission. Int. J. Parasitol. 1999, 29, 851-859.
• Wilson A. J., Mellor P. S.: Bluetongue in Europe: past, present and future. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 2009, 364, 2669-2681.
• Zientara S., Sailleau C., Viarouge C., Hӧper D., Beer M., Jenckel M., Hoffmann B., Romey A., Bakkali-Kassimi L., Fablet A., Vitour D., Breard E.: Novel bluetongue virus in goats, Corsica, France, 2014. Emerg. Infect. Dis. 2014, 20, 2123-2125.

Identyfikatory

DOI

10.21521/mw.5996